CCR1 antagonist 9
CCR1 antagonist 9 is a potent and selective CCR1 antagonist with an IC50 of 6.8 nM in calcium flux assay[1].
Product Specifications
CAS Number
1220026-26-5
UNSPSC
12352005
Target
CCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ccr1-antagonist-9.html
Concentration
10mM
Purity
99.65
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(C1=CN=CC2=C1C=NN2C3=CC=C(F)C=C3)NCC4=CC(S(=O)(C)=O)=NC=C4
Molecular Formula
C20H16FN5O3S
Molecular Weight
425.44
References & Citations
[1]Harcken C, et al. Identification of novel azaindazole CCR1 antagonist clinical candidates. Bioorg Med Chem Lett. 2019 Feb 1;29 (3) :441-448.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCR1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC424152 20 µg
C10orf78 (SFR1) (NM_001002759) Human Over-expression Lysate
Sign In for Pricing
View Details 
